Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Human Molecular Genetics
|
October 16, 2012
Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
Chen Yao, William M Johnson, Yue Gao, et al.
Proteomics. Clinical Applications
|
February 10, 2018
Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine
Jarrod J Sandow, Adam Rainczuk, Giuseppe Infusini, et al.
BMJ Open
|
April 20, 2025
Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol
Sasha R Fehily, Emily K Wright, Chamara Basnayake, et al.
Journal of the Neurological Sciences
|
April 9, 2018
Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls
Steven A Gunzler, David E Riley, Shu G Chen, et al.
Biochemistry
|
February 20, 2016
Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease
William M Johnson, Marcin Golczak, Kyonghwan Choe, et al.
Nutrients
|
September 9, 2022
Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease-The ENIGMA Study
Gina L Trakman, Winnie Y Y Lin, Amy L Hamilton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
July 1, 2022
Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study
Joyce W Y Mak, Sun Yang, Annalise Stanley, et al.
Nature Medicine
|
October 4, 2024
Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
Jiaying Zheng, Qianru Sun, Mengjing Zhang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Human Molecular Genetics
|
October 16, 2012
Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
Chen Yao, William M Johnson, Yue Gao, et al.
Proteomics. Clinical Applications
|
February 10, 2018
Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine
Jarrod J Sandow, Adam Rainczuk, Giuseppe Infusini, et al.
BMJ Open
|
April 20, 2025
Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol
Sasha R Fehily, Emily K Wright, Chamara Basnayake, et al.
Journal of the Neurological Sciences
|
April 9, 2018
Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls
Steven A Gunzler, David E Riley, Shu G Chen, et al.
Biochemistry
|
February 20, 2016
Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease
William M Johnson, Marcin Golczak, Kyonghwan Choe, et al.
Nutrients
|
September 9, 2022
Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease-The ENIGMA Study
Gina L Trakman, Winnie Y Y Lin, Amy L Hamilton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
July 1, 2022
Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study
Joyce W Y Mak, Sun Yang, Annalise Stanley, et al.
Nature Medicine
|
October 4, 2024
Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
Jiaying Zheng, Qianru Sun, Mengjing Zhang, et al.
Page
of 6